The NANOS Annual Meeting Neuro-Ophthalmology Collection: Presentations from the annual meeting of the North American Neuro-Ophthalmology Society (NANOS), a professional organization of more than 600 members who are fully trained ophthalmologists or neurologists. Contains records from the first meeting in 1975 to the present.
NOVEL: https://novel.utah.edu/
TO
Filters: Collection: "ehsl_novel_nam"
| Title | Creator | Relation Is Part Of | ||
|---|---|---|---|---|
| 1 |
 |
Should I Have Teprotumumab or Surgery? | Alison V. Crum, MD | NANOS Annual Meeting 2023: Ophthalmic Surgery in the Neuro-Ophthalmic Patient: https://novel.utah.edu/collection/NAM/toc/ |
| 2 |
 |
Should I Have Teprotumumab or Surgery? | Alison V. Crum, MD | NANOS Annual Meeting 2023: Ophthalmic Surgery in the Neuro-Ophthalmic Patient: https://novel.utah.edu/collection/NAM/toc/ |
| 3 |
 |
Should I Have Teprotumumab or Surgery? | Alison V. Crum, MD | NANOS Annual Meeting 2023: Ophthalmic Surgery in the Neuro-Ophthalmic Patient |
| 4 |
 |
Thyroid Eye Disease - Pilot Study | Frisard; Nicholas E; Rowland, Anne P; Acierno, Marie D; Cockerham, Kimberly P; Hariri, Adham Al | NANOS 2013: Poster Presentations |
| 5 |
 |
Ocular Motility in Thyroid Eye Disease Evaluation and Surgery | Steven E. Feldon, MD, University of Rochester Medical Center | NANOS 2010: IV Thyroid Eye Disease Update |
| 6 |
 |
Ocular Motility in Thyroid Eye Disease Evaluation and Surgery | Steven E. Feldon, MD, University of Rochester Medical Center | NANOS 2010: IV Thyroid Eye Disease Update |
| 7 |
 |
Efficacy of Restasis(R) (0.05% Cyclosporine A) Ophthalmic Emulsion in Patients with Thyroid Eye Disease (TED) | Crow, Lauren; Cockerham, Kimberly; Li, Jing | NANOS 2007: Poster Presentations |
| 8 |
 |
Thyroid Eye Disease in Young Patients Compared with Older | Huna-Baron, Ruth; Katz, Gaby; Leiba, Hana; Hadas, Biatrix; Simon, Guy J Ben | NANOS 2010: Poster Presentations |
| 9 |
 |
Development of Increased Vertical Fusional Amplitudes in Patients with Thyroid Eye Disease | Breker, Dane; Cornblath, Wayne | NANOS 2012: Poster Presentations |
| 10 |
 |
Quantifying Success of Radiation Therapy for Thyroid Optic Neuropathy | Zak, Rochelle S; Winterkorn, J; Rush, S | NANOS 1996: Scientific Platform Presentations (Session 1) |
| 11 |
 |
Orbital Fibroblasts From Thyroid Eye Disease Patients Differ In Proliferative And Adipogenic Responses Depending On Disease Sub-type | Ajay E. Kuriyan, MD, University of Rochester Medical Center; Collynn F. Woeller, MD, University of Rochester Medical Center; Charles W. O'Loughlin, MD, University of Rochester Eye Institute; Richard P. Phipps, MD, University of Rochester Eye Institute; Steven E. Feldon, MD, University of Rochester M... | NANOS 2014: Scientific Platform Presentations (Session 2) |
| 12 |
 |
Orbital Fibroblasts From Thyroid Eye Disease Patients Differ In Proliferative And Adipogenic Responses Depending On Disease Sub-type | Ajay E. Kuriyan, MD, University of Rochester Medical Center; Collynn F. Woeller, MD, University of Rochester Medical Center; Charles W. O'Loughlin, MD, University of Rochester Eye Institute; Richard P. Phipps, MD, University of Rochester Eye Institute; Steven E. Feldon, MD, University of Rochester M... | NANOS 2014: Scientific Platform Presentations (Session 2) |
| 13 |
 |
TED Treatment: Today's Options | Andrea Lora Kossler, MD, FACS | NANOS Annual Meeting 2023: Thyroid Eye Disease: Hiding in Plain Sight?: https://novel.utah.edu/collection/NAM/toc/ |
| 14 |
 |
Adult with Acquired Oblique Diplopia: Do I Image? Do I Operate? (PDF) | Hilda Capó, MD | NANOS Annual Meeting 2020: Strabismus: Image? Operate? |
| 15 |
 |
Orbital Ultrasound as the Primary Imaging Modality in Patients with Ocular Misalignment and Suspected Thyroid Eye Disease | Volpe, Nicholas J; Sbarbaro, james; Gendron, EK; Liu, Grant; Galetta, Steven; Balcer, Laura | NANOS 2003: Scientific Platforms Presentations II |
| 16 |
 |
Objective Markers for Thyroid Eye Disease (TED) Activity, Severity 387 and Progression | Kimberly Cockerham, MD, FACS | NANOS 2010: IV Thyroid Eye Disease Update |
| 17 |
 |
Objective Markers for Thyroid Eye Disease (TED) Activity, Severity 387 and Progression | Kimberly Cockerham, MD, FACS | NANOS 2010: IV Thyroid Eye Disease Update |
| 18 |
 |
Eye Movement Fatigibility in Myasthenia Gravis Observed by Video-oculography | Ju-Hee Chae, Hyun-June Shin, Sun-Young Oh | NAM 2019: Poster Session II: Scientific Advancements in Neuro-Ophthalmology |
| 19 |
 |
Checkpoint inhibitor associated orbital inflammation masquerading as ocular myasthenia gravis and thyroid eye disease | Marisa Tieger, Eric Gaier, Sashank Prasad, Michael Yoon | NAM 2019: Poster Session I: Clinical Highlights in Neuro-Ophthalmology |
| 20 |
 |
Sustainability of Teprotumumab Efficacy in Thyroid Eye Disease | Prem S. Subramanian, Saba Sile, Robert Holt, Raymond Douglas | NANOS Annual Meeting 2022: Scientific Platform III |
| 21 |
 |
Eyetracking in Pediatric Multiple Sclerosis | Andrew Yousef, Michael Deveruex, Pierre-Antoine Gourraud, Soren Jonzzon, Leena Suleiman, Janet Chong, Emmanuelle Waubant, Ari Green, Jennifer Graves | NANOS 2018: Poster Presentations |
| 22 |
 |
Compressive Optic Neuropathy? - A Case of Thyroid-associated Optic Neuropathy without Crowding Orbital Apex | Ko-Jo Lin | NANOS 2018: Poster Presentations |
| 23 |
 |
All Signs Point to Giant Cell Arteritis | Dmitry Balian, Brooke Johnson, Peter MacIntosh | NANOS Annual Meeting 2020: Poster Session I: Clinical Highlights |
| 24 |
 |
Immunology of Thyroid Eye Disease | Feldon, Steven E; Phipps, Richard | NANOS 2007: Immunological Diseases in Neuro-Ophthalmology |
| 25 |
 |
Teprotumumab Efficacy in Retreatment and Longer-Term Thyroid Eye Disease: OPTIC-X Study Results | Raymond Douglas, Saba Sile, Terry Smith, George Kahaly | NANOS Annual Meeting 2021: Scientific Platform Session I |